A citation-based method for searching scientific literature

Patrik Fazio, Cheryl J Fitzer-Attas, Ladislav Mrzljak, Juliana Bronzova, Sangram Nag, John H Warner, Bernhard Landwehrmeyer, Nabil Al-Tawil, Christer Halldin, Anton Forsberg, Jennifer Ware, Valentina Dilda, Andrew Wood, Cristina Sampaio, Andrea Varrone. Mov Disord 2020
Times Cited: 8







List of co-cited articles
72 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Heather Wilson, Flavia Niccolini, Salman Haider, Tiago Reis Marques, Gennaro Pagano, Christopher Coello, Sridhar Natesan, Shitij Kapur, Eugenii A Rabiner, Roger N Gunn,[...]. J Neurol Sci 2016
25
50

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Flavia Niccolini, Salman Haider, Tiago Reis Marques, Nils Muhlert, Andri C Tziortzi, Graham E Searle, Sridhar Natesan, Paola Piccini, Shitij Kapur, Eugenii A Rabiner,[...]. Brain 2015
62
50

Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
David S Russell, Danna L Jennings, Olivier Barret, Gilles D Tamagnan, Vincent M Carroll, Fabien Caillé, David Alagille, Thomas J Morley, Caroline Papin, John P Seibyl,[...]. Neurology 2016
42
50

The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
David S Russell, Olivier Barret, Danna L Jennings, Joseph H Friedman, Gilles D Tamagnan, David Thomae, David Alagille, Thomas J Morley, Caroline Papin, Spyridon Papapetropoulos,[...]. JAMA Neurol 2014
53
50

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Flavia Niccolini, Thomas Foltynie, Tiago Reis Marques, Nils Muhlert, Andri C Tziortzi, Graham E Searle, Sridhar Natesan, Shitij Kapur, Eugenii A Rabiner, Roger N Gunn,[...]. Brain 2015
68
50

Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.
Christine P Diggle, Stacey J Sukoff Rizzo, Michael Popiolek, Reetta Hinttala, Jan-Philip Schülke, Manju A Kurian, Ian M Carr, Alexander F Markham, David T Bonthron, Christopher Watson,[...]. Am J Hum Genet 2016
40
37

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.
Flavia Niccolini, Niccolo E Mencacci, Tayyabah Yousaf, Eugenii A Rabiner, Vincenzo Salpietro, Gennaro Pagano, Bettina Balint, Stephanie Efthymiou, Henry Houlden, Roger N Gunn,[...]. Mov Disord 2018
17
37


Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.
Vahri Beaumont, Sheng Zhong, Hai Lin, WenJin Xu, Amyaouch Bradaia, Esther Steidl, Melanie Gleyzes, Kristian Wadel, Bruno Buisson, Fernando E Padovan-Neto,[...]. Neuron 2016
54
37

PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
Albert Giralt, Ana Saavedra, Olga Carretón, Helena Arumí, Shiraz Tyebji, Jordi Alberch, Esther Pérez-Navarro. Hippocampus 2013
54
37

Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, Giorgio Bernardi, Frank S Menniti, Francesca Romana Fusco. PLoS One 2010
137
37

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
Flavia Niccolini, Heather Wilson, Gennaro Pagano, Christopher Coello, Mitul A Mehta, Graham E Searle, Roger N Gunn, Eugenii A Rabiner, Thomas Foltynie, Marios Politis. Neurology 2017
22
37

Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain.
Michy P Kelly, Wendy Adamowicz, Susan Bove, Alexander J Hartman, Abigail Mariga, Geetanjali Pathak, Veronica Reinhart, Alison Romegialli, Robin J Kleiman. Cell Signal 2014
73
37

Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease.
Gennaro Pagano, Flavia Niccolini, Heather Wilson, Tayyabah Yousaf, Naheed L Khan, Davide Martino, Christophe Plisson, Roger N Gunn, Eugenii A Rabiner, Paola Piccini,[...]. Mov Disord 2019
7
42

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.
Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A Shivak, Qi Yu, Davis Li, Jocelynn R Pearl, Jeffrey C Miller, Lei Zhang, David E Paschon,[...]. Nat Med 2019
58
25

Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival.
Paul Morgan, Piet H Van Der Graaf, John Arrowsmith, Doug E Feltner, Kira S Drummond, Craig D Wegner, Steve D A Street. Drug Discov Today 2012
383
25

Mutations in GNAL cause primary torsion dystonia.
Tania Fuchs, Rachel Saunders-Pullman, Ikuo Masuho, Marta San Luciano, Deborah Raymond, Stewart Factor, Anthony E Lang, Tsao-Wei Liang, Richard M Trosch, Sierra White,[...]. Nat Genet 2013
192
25

A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea.
Vincenzo Salpietro, Belen Perez-Dueñas, Kosuke Nakashima, Victoria San Antonio-Arce, Andreea Manole, Stephanie Efthymiou, Jana Vandrovcova, Conceicao Bettencourt, Niccolò E Mencacci, Christine Klein,[...]. Mov Disord 2018
23
25


Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia.
Diane Doummar, Christel Dentel, Romane Lyautey, Julia Metreau, Boris Keren, Nathalie Drouot, Ludivine Malherbe, Viviane Bouilleret, Jérémie Courraud, Maria Paola Valenti-Hirsch,[...]. Eur J Hum Genet 2020
7
28

Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
Ying-Zhang Chen, Jennifer R Friedman, Dong-Hui Chen, Guy C-K Chan, Cinnamon S Bloss, Fuki M Hisama, Sarah E Topol, Andrew R Carson, Phillip H Pham, Emily S Bonkowski,[...]. Ann Neurol 2014
76
25

Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice.
Louise-Laure Mariani, Sophie Longueville, Jean-Antoine Girault, Denis Hervé, Nicolas Gervasi. Neurobiol Dis 2019
6
33

Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme.
Gonzalo S Tejeda, Ellanor L Whiteley, Tarek Z Deeb, Roland W Bürli, Stephen J Moss, Eamonn Sheridan, Nicholas J Brandon, George S Baillie. Proc Natl Acad Sci U S A 2020
6
33

A familial case of PDE10A-associated childhood-onset chorea with bilateral striatal lesions.
Satoko Miyatake, Eriko Koshimizu, Ikuko Shirai, Satoko Kumada, Yasuhiro Nakata, Aiko Kamemaru, Mitsuko Nakashima, Takeshi Mizuguchi, Noriko Miyake, Hirotomo Saitsu,[...]. Mov Disord 2018
6
33

A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations.
Silvia Esposito, Miryam Carecchio, Davide Tonduti, Veronica Saletti, Celeste Panteghini, Luisa Chiapparini, Giovanna Zorzi, Chiara Pantaleoni, Barbara Garavaglia, Dimitri Krainc,[...]. Mov Disord 2017
10
25

PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
Rawaha Ahmad, Sophie Bourgeois, Andrey Postnov, Mark E Schmidt, Guy Bormans, Koen Van Laere, Wim Vandenberghe. Neurology 2014
53
25

Familial choreoathetosis due to novel heterozygous mutation in PDE10A.
Dhanya L Narayanan, Dipti Deshpande, Aneek Das Bhowmik, Dandu R Varma, Ashwin Dalal. Am J Med Genet A 2018
8
25

Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
Akinori Nishi, Mahomi Kuroiwa, Diane B Miller, James P O'Callaghan, Helen S Bateup, Takahide Shuto, Naoki Sotogaku, Takaichi Fukuda, Nathaniel Heintz, Paul Greengard,[...]. J Neurosci 2008
190
25

De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
Niccolò E Mencacci, Erik-Jan Kamsteeg, Kosuke Nakashima, Lea R'Bibo, David S Lynch, Bettina Balint, Michèl A A P Willemsen, Matthew E Adams, Sarah Wiethoff, Kazunori Suzuki,[...]. Am J Hum Genet 2016
62
25

ADCY5 mutations are another cause of benign hereditary chorea.
Niccolo E Mencacci, Roberto Erro, Sarah Wiethoff, Joshua Hersheson, Mina Ryten, Bettina Balint, Christos Ganos, Maria Stamelou, Niall Quinn, Henry Houlden,[...]. Neurology 2015
50
25

A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration.
Reo Azuma, Kinya Ishikawa, Kosei Hirata, Yuji Hashimoto, Makoto Takahashi, Kenji Ishii, Akira Inaba, Takanori Yokota, Satoshi Orimo. Mov Disord 2015
9
25

Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.
Heng Du, Lan Guo, Xiaoping Wu, Alexander A Sosunov, Guy M McKhann, John Xi Chen, Shirley ShiDu Yan. Biochim Biophys Acta 2014
59
25

Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.
Lichuan Yang, Noel Y Calingasan, Beverly J Lorenzo, M Flint Beal. Exp Neurol 2008
45
25

Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
Alessandro Leuti, Daunia Laurenti, Carmela Giampà, Elena Montagna, Clemente Dato, Serenella Anzilotti, Mariarosa A B Melone, Giorgio Bernardi, Francesca R Fusco. Neurobiol Dis 2013
36
25

Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation.
Giuseppe Sancesario, Mauro Giorgi, Vincenza D'Angelo, Anna Modica, Alessandro Martorana, Maria Morello, C Peter Bengtson, Giorgio Bernardi. Eur J Neurosci 2004
53
25

Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.
Jole Fiorito, Jeremie Vendome, Faisal Saeed, Agnieszka Staniszewski, Hong Zhang, Shijun Yan, Shi-Xian Deng, Ottavio Arancio, Donald W Landry. J Med Chem 2017
22
25

PDE11A negatively regulates lithium responsivity.
G Pathak, M J Agostino, K Bishara, W R Capell, J L Fisher, S Hegde, B A Ibrahim, K Pilarzyk, C Sabin, T Tuczkewycz,[...]. Mol Psychiatry 2017
15
25

Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington's disease.
Motomasa Tanaka, Koko Ishizuka, Yoko Nekooki-Machida, Ryo Endo, Noriko Takashima, Hideyuki Sasaki, Yusuke Komi, Amy Gathercole, Elaine Huston, Kazuhiro Ishii,[...]. J Clin Invest 2017
21
25

cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex.
Becky C Carlyle, Angus C Nairn, Min Wang, Yang Yang, Lu E Jin, Arthur A Simen, Brian P Ramos, Kelly A Bordner, George E Craft, Peter Davies,[...]. Proc Natl Acad Sci U S A 2014
75
25


Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice.
Shweta Hegde, Will R Capell, Baher A Ibrahim, Jennifer Klett, Neema S Patel, Alexander T Sougiannis, Michy P Kelly. Neuropsychopharmacology 2016
19
25

Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.
Ana Saavedra, Albert Giralt, Helena Arumí, Jordi Alberch, Esther Pérez-Navarro. PLoS One 2013
43
25

Phosphodiesterase isoform-specific expression induced by traumatic brain injury.
Anthony A Oliva, Yuan Kang, Concepcion Furones, Ofelia F Alonso, Olga Bruno, W Dalton Dietrich, Coleen M Atkins. J Neurochem 2012
21
25


Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons.
Hai-Hong Wang, Yan Li, Ang Li, Fang Yan, Zhen-Lin Li, Zhong-Ying Liu, Lei Zhang, Jian Zhang, Wei-Ren Dong, Lin Zhang. Mol Neurobiol 2018
9
25

Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
Giuseppe Sancesario, Luigi Antonio Morrone, Vincenza D'Angelo, Valentina Castelli, Davide Ferrazzoli, Francesco Sica, Alessandro Martorana, Roberto Sorge, Federica Cavaliere, Giorgio Bernardi,[...]. Neurochem Int 2014
19
25

Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.
Silvia Gines, Ihn Sik Seong, Elisa Fossale, Elena Ivanova, Flavia Trettel, James F Gusella, Vanessa C Wheeler, Francesca Persichetti, Marcy E MacDonald. Hum Mol Genet 2003
201
25

Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.
Amy J Tibbo, Gonzalo S Tejeda, George S Baillie. Biochem Soc Trans 2019
10
25

Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
Carmela Giampà, Stefano Patassini, Antonella Borreca, Daunia Laurenti, Fabrizia Marullo, Giorgio Bernardi, Frank S Menniti, Francesca R Fusco. Neurobiol Dis 2009
57
25

Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A.
Haibei Hu, Elizabeth A McCaw, Andrea L O Hebb, Geraldine T Gomez, Eileen M Denovan-Wright. Eur J Neurosci 2004
59
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.